Cargando…
Type 3 ILCs in Lung Disease
The lungs represent a complex immune setting, balancing external environmental signals with a poised immune response that must protect from infection, mediate tissue repair, and maintain lung function. Innate lymphoid cells (ILCs) play a central role in tissue repair and homeostasis, and mediate pro...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361816/ https://www.ncbi.nlm.nih.gov/pubmed/30761149 http://dx.doi.org/10.3389/fimmu.2019.00092 |
_version_ | 1783392747122589696 |
---|---|
author | Ardain, Amanda Porterfield, James Zachary Kløverpris, Henrik N. Leslie, Alasdair |
author_facet | Ardain, Amanda Porterfield, James Zachary Kløverpris, Henrik N. Leslie, Alasdair |
author_sort | Ardain, Amanda |
collection | PubMed |
description | The lungs represent a complex immune setting, balancing external environmental signals with a poised immune response that must protect from infection, mediate tissue repair, and maintain lung function. Innate lymphoid cells (ILCs) play a central role in tissue repair and homeostasis, and mediate protective immunity in a variety of mucosal tissues, including the lung. All three ILC subsets are present in the airways of both mice and humans; and ILC2s shown to have pivotal roles in asthma, airway hyper-responsiveness, and parasitic worm infection. The involvement of ILC3s in respiratory diseases is less well-defined, but they are known to be critical in homeostasis, infection and inflammation at other mucosal barriers, such as the gut. Moreover, they are important players in the IL17/IL22 axis, which is key to lung health. In this review, we discuss the emerging role of ILC3s in the context of infectious and inflammatory lung diseases, with a focus on data from human subjects. |
format | Online Article Text |
id | pubmed-6361816 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63618162019-02-13 Type 3 ILCs in Lung Disease Ardain, Amanda Porterfield, James Zachary Kløverpris, Henrik N. Leslie, Alasdair Front Immunol Immunology The lungs represent a complex immune setting, balancing external environmental signals with a poised immune response that must protect from infection, mediate tissue repair, and maintain lung function. Innate lymphoid cells (ILCs) play a central role in tissue repair and homeostasis, and mediate protective immunity in a variety of mucosal tissues, including the lung. All three ILC subsets are present in the airways of both mice and humans; and ILC2s shown to have pivotal roles in asthma, airway hyper-responsiveness, and parasitic worm infection. The involvement of ILC3s in respiratory diseases is less well-defined, but they are known to be critical in homeostasis, infection and inflammation at other mucosal barriers, such as the gut. Moreover, they are important players in the IL17/IL22 axis, which is key to lung health. In this review, we discuss the emerging role of ILC3s in the context of infectious and inflammatory lung diseases, with a focus on data from human subjects. Frontiers Media S.A. 2019-01-29 /pmc/articles/PMC6361816/ /pubmed/30761149 http://dx.doi.org/10.3389/fimmu.2019.00092 Text en Copyright © 2019 Ardain, Porterfield, Kløverpris and Leslie. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Ardain, Amanda Porterfield, James Zachary Kløverpris, Henrik N. Leslie, Alasdair Type 3 ILCs in Lung Disease |
title | Type 3 ILCs in Lung Disease |
title_full | Type 3 ILCs in Lung Disease |
title_fullStr | Type 3 ILCs in Lung Disease |
title_full_unstemmed | Type 3 ILCs in Lung Disease |
title_short | Type 3 ILCs in Lung Disease |
title_sort | type 3 ilcs in lung disease |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361816/ https://www.ncbi.nlm.nih.gov/pubmed/30761149 http://dx.doi.org/10.3389/fimmu.2019.00092 |
work_keys_str_mv | AT ardainamanda type3ilcsinlungdisease AT porterfieldjameszachary type3ilcsinlungdisease AT kløverprishenrikn type3ilcsinlungdisease AT lesliealasdair type3ilcsinlungdisease |